Abstract:BACKGROUND:DeltaDNMT3B (a new DNMT3B subfamily) expression is initiated through a novel promoter. We identified at least 7 transcription variants of deltaDNMT3B as a result of alternative pre-mRNA processing. The aim of this study was to detect the expression pattern of deltaDNMT3B variants in non-small cell lung cancer (NSCLC) and to explore the role of deltaDNMT3B variants in regulating the promoter-specific DNA methylation.METHODS:Specific polymerase chain reaction (PCR) primer sets were designed to distinguish individual deltaDNMT3B variants according to their splicing patterns. The expressions of seven deltaDNMT3B variants were measured in 13 cell lines, 109 NSCLC patients, and the corresponding normal lung tissues using reverse transcription-PCR (RT-PCR). The status of the p16 and RASSF1A promoter methylations in the tumors was detected using a methylation specific PCR (MSP). The relationships of the expression patterns of the deltaDNMT3B variants were analyzed by observing the status of p16 and RASSF1A promoter methylations in the tumors. The siRNA and the anti-sense oligo-dioxynucleotide specifically targeting the junction of exon 5 and 7 of deltaDNMT3B were designed and transfected by lipofectmane 2000 into H1299 and H358 cell lines. RASSF1A promoter methylation from cells treated by siRNA-deltaDNMT3B4/2 was detected using MSP and Bisulfite sequencing, and Western blotting was used to detect the protein expression of DNMT3B and ADNMT3B. Cell growth and cell cycle distribution were measured by applying real-time cell growth analysis and flowcytometry, respectively.RESULTS:ADNMT3B variants, not DNMT3B, were the predominant transcripts in both NSCLC cell lines and primary tumors. The expression of deltaDNMT3B4 strongly correlated to the promoter methylation status of RASSF1A in a primary NSCLC. The knockdown of deltaDNMT3B4/2 by RNA-interference or anti-sense approaches resulted in a complete demethylation of RASSF1A promoter with the reactivation of a RASSF1A gene expression in less than 12 hours, but no effect resulted from the p16(INK4a) promoter in the NSCLC cell lines.CONCLUSIONS:These results demonstrate an important role of deltaDNMT3B4/2 in the maintenance of promoter-specific DNA methylation in a cell type specific manner and provide a novel cell model for the study of the regulation of replication-independent DNA methylation.

14-3-3 Sigma Promoter De-Methylation and Gene Expression in Nasopharyngeal Carcinoma Cell Lines

Influence of 5-Aza-2'-deoxycytidine on Cell Cycle of Nasopharyngeal Carcinoma Cell Lines and Methylation of 14-3-3σ Gene

Inactivation Of 14-3-3 Sigma By Promoter Methylation Correlates With Metastasis In Nasopharyngeal Carcinoma

Hypermethylation Leads to Down-regulated 14-3-3 Sigma Expression in Nasopharyngeal Carcinoma Tissues*

Effect of 5-Aza-CdR on methylation and mRNA expression of RASSF1A gene in nasopharyngeal carcinoma cells

Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma

Subtelomeric Demethylation Deregulated Htert Expression, Telomerase Activity, and Telomere Length in Four Nasopharyngeal Carcinoma Cell Lines.

Effects of DACT1 Methylation Status on Invasion and Metastasis of Nasopharyngeal Carcinoma

Differential proteomic analysis of 5-aza-2-dC treated and untreated nasopharyngeal carcinoma cells

Correlation between methylation status of tumor-related genes and mRNA transcriptional level in lung cancer cell lines.

Progression of 14-3-3σ in nasopharyngeal carcinoma

Gene Methylation Inhibits the Expression of Squamous Cell Carcinoma Antigen 1 in Nasopharyngeal Carcinoma Tissues

Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas

Mechanism of 5-Aza-2′-deoxycytidine Inhibiting the Growth of CNE Cell Line

Critical Role of Delta Dnmt3b4/2 in Regulating Rassf1a Promoter-Specific Dna Methylation in Non-Small Cell Lung Cancer

Clinical significance of hMLH1 gene methylation and protein expression in nasopharyngeal carcinoma

Quantitative Assessment of Gene Promoter Methylation in Non-Small Cell Lung Cancer Using Methylation-Sensitive High-Resolution Melting.

SEPT9_v2, Frequently Silenced by Promoter Hypermethylation, Exerts Anti-Tumor Functions Through Inactivation of Wnt/β-catenin Signaling Pathway Via Mir92b-3P/fzd10 in Nasopharyngeal Carcinoma Cells

Promoter Methylation Inhibits BRD7 Expression in Human Nasopharyngeal Carcinoma Cells

Inhibitory effect of histone H3K27 methylation on proliferation of human well-differentiated nasopharyngeal carcinoma cell line CNE-1

Uncovering the ceRNA network and DNA methylation associated with gene expression in nasopharyngeal carcinoma